<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Immunotherapy response &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/immunotherapy-response/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Thu, 17 Apr 2025 17:06:28 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Immunotherapy response &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Circulating Tumor Cells in Advanced Gallbladder Cancer</title>
		<link>https://bioengineer.org/circulating-tumor-cells-in-advanced-gallbladder-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 17 Apr 2025 17:06:28 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Advanced gallbladder adenocarcinoma]]></category>
		<category><![CDATA[Circulating tumor cells]]></category>
		<category><![CDATA[Immunotherapy response]]></category>
		<category><![CDATA[Liquid biopsy applications]]></category>
		<category><![CDATA[Prognostic biomarkers]]></category>
		<guid isPermaLink="false">https://bioengineer.org/circulating-tumor-cells-in-advanced-gallbladder-cancer/</guid>

					<description><![CDATA[In a groundbreaking study published in the latest issue of BMC Cancer, researchers have elucidated the pivotal role of circulating tumor cells (CTCs) in the prognosis and treatment response of patients suffering from advanced gallbladder adenocarcinoma (aGA). This research marks one of the first comprehensive explorations into how CTC enumeration and classification can be harnessed [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">241394</post-id>	</item>
	</channel>
</rss>
